相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues
Eiman Elwakeel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy
Jenniffer Linares et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Restoring IL-2 to its cancer immunotherapy glory
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism
Jerod L. Ptacin et al.
NATURE COMMUNICATIONS (2021)
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy
Inja Waldhauer et al.
MABS (2021)
A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
Weiqi Hong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
Patricia Fernandez-Nogueira et al.
CLINICAL CANCER RESEARCH (2020)
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies
Steven N. Quayle et al.
CLINICAL CANCER RESEARCH (2020)
Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer
Amir Sonnenblick et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
Floriane Pelon et al.
NATURE COMMUNICATIONS (2020)
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
Adi Diab et al.
CANCER DISCOVERY (2020)
Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer
Yann Kieffer et al.
CANCER DISCOVERY (2020)
Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy
Ghita Chabab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome
Gil Friedman et al.
NATURE CANCER (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
Claire Bonneau et al.
BREAST CANCER RESEARCH (2020)
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial
Sherene Loi et al.
LANCET ONCOLOGY (2019)
Improving the outcomes of checkpoint inhibitors in breast cancer
George E. Peoples
LANCET ONCOLOGY (2019)
The emerging roles of inflammasome-dependent cytokines in cancer development
Hanne Van Gorp et al.
EMBO REPORTS (2019)
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
Uku Raudvere et al.
NUCLEIC ACIDS RESEARCH (2019)
A human liver cell atlas reveals heterogeneity and epithelial progenitors
Nadim Aizarani et al.
NATURE (2019)
Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer
Yulia Liubomirski et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
Lea Monteran et al.
FRONTIERS IN IMMUNOLOGY (2019)
The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
C. J. H. Kramer et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
Aura Muntasell et al.
CLINICAL CANCER RESEARCH (2019)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa et al.
CANCER CELL (2018)
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype
Jeremy Force et al.
CLINICAL BREAST CANCER (2018)
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update
Neelima Denduluri et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Principles and approaches for reproducible scoring of tissue stains in research
David K. Meyerholz et al.
LABORATORY INVESTIGATION (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer
Cesar August Santa-Maria et al.
Oncotarget (2018)
Safety, PK/PD, and anti-tumor activity of RO6874281, an engineered variant of interleukin-2 (IL-2v) targeted to tumor-associated fibroblasts via binding to fibroblast activation protein (FAP).
Morten Mau Soerensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
Ankur Chakravarthy et al.
NATURE COMMUNICATIONS (2018)
Dissecting Effects of Anti-cancer Drugs and Cancer-Associated Fibroblasts by On-Chip Reconstitution of Immunocompetent Tumor Microenvironments
Marie Nguyen et al.
CELL REPORTS (2018)
A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents
Sylvia Herter et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Immunotherapy for Breast Cancer: What Are We Missing?
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2017)
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer
Barbara Ingold Heppner et al.
CLINICAL CANCER RESEARCH (2016)
Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation
Jernej Godec et al.
IMMUNITY (2016)
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Ian B. Robertson et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Sasha E. Stanton et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration
Kingsley O. Osuala et al.
BMC CANCER (2015)
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Alexandre Calon et al.
NATURE GENETICS (2015)
HER2-directed therapy: current treatment options for HER2-positive breast cancer
Shahid Ahmed et al.
BREAST CANCER (2015)
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration
Tiziana Triulzi et al.
ONCOTARGET (2015)
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab A Secondary Analysis of the NeoALTTO Trial
Roberto Salgado et al.
JAMA ONCOLOGY (2015)
Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
Aleix Prat et al.
CLINICAL CANCER RESEARCH (2014)
Advances and Future Directions in the Targeting of HER2-positive Breast Cancer: Implications for the Future
Ishwaria M. Subbiah et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Alexandre Calon et al.
CANCER CELL (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
Jan Budczies et al.
PLOS ONE (2012)
Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients
Erick Roman-Perez et al.
BREAST CANCER RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Brian F. Zamarron et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
Aude-Helene Capietto et al.
JOURNAL OF IMMUNOLOGY (2011)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab
Aruna Mani et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development
LR Kelland
EUROPEAN JOURNAL OF CANCER (2004)
Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors
C Lois et al.
SCIENCE (2002)
分享论文
